Home/Filings/4/0001209191-18-045024
4//SEC Filing

Mancilla Bethany 4

Accession 0001209191-18-045024

CIK 0001645460other

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 5:14 PM ET

Size

5.3 KB

Accession

0001209191-18-045024

Insider Transaction Report

Form 4
Period: 2018-08-01
Mancilla Bethany
SVP and Chief Business Officer
Transactions
  • Award

    Stock Option (right to buy)

    2018-08-01+250,000250,000 total
    Exercise: $9.54Exp: 2025-08-01Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]This stock option grant becomes exercisable in eight equal semi-annual installments beginning February 1, 2019.

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1
  • filerCIK 0001748840

Filing Metadata

Form type
4
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 5:14 PM ET
Size
5.3 KB